Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of oral N-acetylcysteine for prevention of oral mucositis after high-dose chemotherapy and autologous bone marrow transplantation
MOH_2021-02-25_009790Phase 3Not yet recruiting
- Sponsor
- משה ישורון
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of acetylcysteine in stomatitis (2 arms), sponsored by משה ישורון. Primary endpoints: Incidence of oral mucositis and Severity of oral mucositis. Planned start Feb 2021; status: not yet recruiting.
02
Drugs
acetylcysteine
03
Conditions
stomatitis
Beyond the preview
Go deeper on MOH_2021-02-25_009790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-02-25_009790.